VIM and neoplasm: In the BT-549 model, reactivation of epithelial properties mediated by PRRX1 loss, upregulation of E-cadherin, and loss of Vimentin resulted in tumor-initiating ability and MET, followed by formation of the metastatic foci in lungs.